CD8A and neoplasm: Taken together, these data indicate that TRT led to an acute increase in PD-L1 expression on T cells, and that TRT combined with anti-PD-L1 mAb synergistically enhances anti-tumor immunity by stimulating CD8+ T cell infiltration.